Cat.#: ASSD-131
Description | Fluorescent metal ion indicator. Exhibits resistance to alkaline hydrolysis and displays similar calcium-binding properties to calcein. It fluoresces in both acidic and basic solutions when excited by the correct wavelength. Enhanced fluorescence is shown when bound to Ca (II), La (II) and Zn (II). Reduced fluorescence is shown when bound to Fe (II), Cu (II), Ni (II), Mn (II) and Co (II). |
Size | 1 mg |
Molecule Weight | 321.28 |
Molecular formula | C15H15NO7 |
CAS Number | 54375-47-2 |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
ASSD-167 | Fura-2 AM (Cell permeant) (AC167) | 1 mg | inquiry |
ASSD-156 | Crystal Violet (AC156) | 1g, 5g | inquiry |
ASSD-144 | Oxazole Yellow Iodide (AC144) | 1 mg | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
ASSD-135 | JC-1 (AC135) | 5 mg | inquiry |
ASSD-132 | Congo Red (AC132) | 100 mg, 1g | inquiry |
ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
ASSD-221 | Antifade Fluorescence Mounting Medium with DAPI (hard set) (AC221) | 10 mL | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.